The Journal of Bone and Joint Surgery (American). 2009;91:2617-2621.
doi:10.2106/JBJS.H.01201
© 2009 The Journal of Bone and Joint Surgery, Inc.
Survivorship of a Charnley Total Hip ArthroplastyA Concise Follow-up, at a Minimum of Thirty-five Years, of Previous Reports*
John J. Callaghan, MD1,
Peter Bracha1,
Steve S. Liu, MD1,
Somyot Piyaworakhun, MD1,
Devon D. Goetz, MD2 and
Richard C. Johnston, MD1
1 University of Iowa and VA Medical Center, 200 Hawkins Drive, UIHC, 01029 JPP, Iowa City, IA 52242. E-mail address for J.J. Callaghan: john-callaghan{at}uiowa.edu
2 Des Moines Orthopaedic Surgeons, 6001 Westown Parkway, West Des Moines, IA 50266
Investigation performed at the University of Iowa, Iowa City, Iowa, and Des Moines Orthopaedic Surgeons, West Des Moines, Iowa
* Original Publications
Johnston RC. Clinical follow-up of total hip replacement. Clin Orthop Relat Res. 1973;95:118-26.
Johnston RC, Crowninshield RD. Roentgenologic results of total hip arthroplasty. A ten-year follow-up study. Clin Orthop Relat Res. 1983;181:92-8.
Schulte KR, Callaghan JJ, Kelly SS, Johnston RC. The outcome of Charnley total hip arthroplasty with cement after a minimum twenty-year follow-up. The results of one surgeon. J Bone Joint Surg Am. 1993;75:961-75. Erratum in: J Bone Joint Surg Am. 1993;75:1418.
Callaghan JJ, Albright JC, Goetz DD, Olejniczak JP, Johnston RC. Charnley total hip arthroplasty with cement. Minimum twenty-five-year follow-up. J Bone Joint Surg Am. 2000;82:487-97.
Callaghan JJ, Templeton JE, Liu SS, Pedersen DR, Goetz DD, Sullivan PM, Johnston RC. Results of Charnley total hip arthroplasty at a minimum of thirty years. A concise follow-up of a previous report. J Bone Joint Surg Am. 2004;86:690-5.
Disclosure: The authors did not receive any outside funding or grants in support of their research for or preparation of this work. One or more of the authors or a member of his or her immediate family received, in any one year, payments (royalties) or other benefits in excess of $10,000 or a commitment or agreement to provide such benefits from commercial entities (DePuy and Zimmer). Also, a commercial entity (DePuy) paid or directed in any one year, or agreed to pay or direct, benefits in excess of $10,000 to a research fund, foundation, division, center, clinical practice, or other charitable or nonprofit organization with which one or more of the authors, or a member of his or her immediate family, is affiliated or associated.
The purpose of this study was to update the results, at a minimum of thirty-five years, in a single-surgeon series of primary Charnley total hip arthroplasties performed with cement. Twelve patients (fifteen hips) were alive, 249 patients (314 hips) had died, and one patient (one hip) had been lost to follow-up. Seven of the hips in the living patients had required at least one revision; 290 (88%) of the original group of total hip prostheses either continued to function or were in patients who had died. Since the time of a thirty-year study of this cohort, one hip that had previously been revised because of acetabular loosening required an additional revision because of acetabular loosening and two additional hips had evidence of radiographic loosening (of one acetabular and one femoral component). The survival rate with revision for any reason as the end point was 78%. This end result study should provide a benchmark for subsequent procedures and designs with the caveat that patient life expectancy will likely continue to increase and modern-design implants are being used in younger patients.
Level of Evidence: Therapeutic Level IV. See Instructions to Authors for a complete description of levels of evidence.

CiteULike Connotea Del.icio.us Facebook Technorati Twitter What's this?
|